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ABSTRACT 
Reduced  glutathione,  in  concentrations  approximating  those  occurring  in 
intact rat liver, causes swelling of rat liver mitochondria in vitro which is different 
in kinetics and extent from that yielded by L-thyroxine. The effect is also given 
by cysteine, which is more active, and reduced coenzyme A, but not by L-ascor- 
bate,  cystine, or oxidized glutathione.  The optimum pH is 6.5,  whereas thyrox- 
ine-induced swelling is optimal at pH 7.5. 
The GSH-induced swelling is not inhibited by DNP or dicumarol, nor by high 
concentrations  of  sucrose,  serum  albumin,  or po]yvinylpyrrolidone, in  contrast 
to  thyroxine-induced  swelling.  ATP  inhibits  the  GSH  swelling,  but  ADP  and 
AMP are ineffective. Mn  ++ is a  very potent inhibitor,  but  Mg  ++ is ineffective. 
Ethylenediaminetetraacetate is also an effective inhibitor of GSH-induced swell- 
ing. The respiratory inhibitors amytal and antimycin A do not inhibit the swell- 
ing action of GSH, but cyanide does; these findings  are consistent with the view 
that  the oxidation-reduction state  of the respiratory chain  between cytochrome 
c and oxygen is a determinant of GSH-induced swelling. 
Reversal of GSH-induced swelling by osmotic means or by ATP in KCI media 
could not be observed.  Large losses  of nueleotides and protein occur during the 
swelling by GSH, suggesting that the action is irreversible. The characteristically 
drastic swelling action of GSH could be prevented if L-thyroxine was also present 
in the medium. 
A  number  of  agents  cause  swelling  of  isolated 
rat  liver  mitochondria  suspended  in  buffered 
sucrose  solutions.  These  include  thyroxine  and 
other  thyroactive  compounds  (1-3),  inorganic 
phosphate  (4,  5),  Ca  ++ (1,  4,  6), heavy metal ions 
and  certain  of  their derivatives,  such  as Ag  +  and 
p-chloromercuribenzoate  (1,  7),  phloridzin  (8), 
and  some  detergents  (9,  10).  Of  these  agents, 
thyroxine,  Ca  ++  and  phosphate  occur  physio- 
logically  in  concentrations  capable  of  affecting 
mitochondrial swelling, and presumably contribute 
to  the  balance  of  intracellular  factors  affecting 
the  morphological  and  physiological  state  of  the 
mitochondria  (3). 
This  paper  reports  the  finding  that  reduced 
glutathione  (GSH),  and  also  cysteine,  cause  very 
pronounced and characteristic mitochondrial swell- 
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ing  in  vitro. This  effect  is  noteworthy  because 
concentrations  of  reduced  glutathione  equivalent 
to  those  found  in  fresh  intact  liver  readily  pro- 
duce  maximal  swelling  effects,  suggesting  that 
GSH may also be an intracellular factor concerned 
in  maintaining  the  dynamic  balance  between 
swelling  of  mitochondria  and  the  "active"  con- 
traction.  Another  significant  feature  of  GSH- 
induced  swelling  is  that  it  differs  very strikingly 
from  that  induced  by  thyroxine  with  respect  to 
kinetics,  extent,  inhibition,  and  reversal,  suggest- 
ing  that  the  two  different kinds  of mitochondrial 
swelling  originate  from  rather  different  initial 
biochemical  events  and  result  in  different  types 
of morphological change. 
Experimental 
Rat  liver  mitochondria  were  prepared  exactly  as 
described in the preceding communication on thyroxine- 
induced swelling  (3); they were used within 2 hours of 
preparation.  The  standard  test  system  was  0.3 
sucrose-0.02  •  tris  (hydroxymethyl)aminomethane- 
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(tris)-HCl,  pH  7.4,  unless otherwise designated.  Solu- 
tions of sulfhydryl compounds were prepared and care- 
fully brought  to pH 7.4  at 0 ° just before use in order 
to minimize autoxidation by atmospheric oxygen. 
Swelling  Action  of  GSH  and  Cysteine.--GSH 
and  cysteine  cause  a  type  of swelling of rat  liver 
mitochondria  which  differs  strikingly  in  extent 
and  kinetics  from  spontaneous  or  thyroxine-in- 
duced swelling, which the preceding study demon- 
strated  to  be  essentially  similar  (3).  In  Fig.  1  is 
shown  a  comparison  of  the action of 0.01  M GSH 
and  1  )<  10  -5 M thyroxine in a  typical experiment. 
As  shown  before,  thyroxine-induced  swelling  is 
characterized  by  a  relatively  short  lag  period, 
usually  absent  above  20-25 ° ,  followed  by  rapid 
swelling  which  approaches  asymptotically  a 
terminal  optical  absorbancy  at  520  m/,  of  about 
30  per  cent  of  the  initial  absorbancy  under  the 
optical  and  geometrical  conditions  of  measure- 
ment  used  (3).  GSH,  in  contrast,  shows  a  sub- 
stantially  longer  lag  period  followed  by  a  rather 
precipitous  drop  in  absorbancy  to  an  end  value 
which is asymptotic to an optically clear solution. 
This  characteristic  picture  is given by  GSH  con- 
centrations of 0.005 M and above with freshly pre- 
pared  mitochondria.  At  lower  concentrations  of 
GSH  the  lag  period  is longer.  After aging  of  the 
mitochondria at 0 °  they become more sensitive to 
low  concentrations  of  GSH  and  the  lag period  is 
shorter.  For  comparison,  the  concentration  of 
GSH  in  fresh  rat  tissues  ranges  from  0.003  M to 
Fro. 1. Kinetics and extent of GSH- and thyroxine- 
induced swelling. The medium was 0.3 M sucrose-0.02 
tris pH  7.4  at 20.0°C.;  final concentrations of 0.01  M 
GSH and  1 X  10  .5 ~  L-thyroxine present at zero time 
as shown. Aliquots of rat liver mitoehondrial suspension 
containing  50  mg.  tissue  equivalent  of  mitoehondria 
added  at  zero  time.  Optical  absorbancy  measured  at 
520 m#. 
FIG. 2. Effect of cysteine concentration on swelling. 
Details as in Fig. 1; freshly neutralized cysteine added 
in concentrations shown. 
0.02  M;  in  rat  liver  the  GSH  concentration  is 
about  0.005-0.008  •  (11,  12).  These  tests  were 
carried  out  at  pH  7.4;  experiments  described 
below  show  that  mitochondria  are  considerably 
more susceptible  to  GSH-induced  swelling at pH 
6.5-7.0. 
Cysteine  is  a  far  more  potent  swelling  agent 
than GSH; data in Fig. 2 show that concentrations 
as  low  as  0.003  M produce  about  the  same  effect 
as 0.01  ~t GSH, However at higher concentrations 
(0.01  M) the action of cysteine is much less drastic; 
the  data  show  a  biphasic  swelling  response  to 
cysteine concentration. 
Substantial  swelling  is  also  given  by  the  re- 
duced  form  of  coenzyrne  A  at  0.001  M,  but  little 
or no  swelling occurred  with 0.005  vl thioethanol, 
0.001  M  BAL  (2,3-propanedithiol),  0.001  M  re- 
duced  DL-lipoic  acid,  or  0.01  M methionine.  Sig- 
nificantly,  L-ascorbate  at  0.01  ~t  does  not  cause 
mitochondrial  swelling. 
Neither oxidized glutathione  nor cystine causes 
swelling  of  rat  liver  mitochondria,  nor  do  they 
alter  the  response  to  GSH  or  cysteine.  However 
0.001  M oxidized lipoic acid did increase the swell- 
ing rate. 
In a  medium of 0.15  M KC1-0.02  ~t tris pH  7.4, 
GSH  also  is  effective in  promoting  the  swelling. 
However, the  terminal optical absorbancy  is sub- 
stantially  higher  than  in  sucrose,  suggesting  that 
in KC1 GSH-induced swelling is much less drastic. 
Factors Affecting  the Swelling  Action  of GSH.-- 
Swelling of mitochondria by thyroxine is inhibited 
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FIG. 3. Effect of 2,4-dinitrophenol  (DNP).  General 
conditions  as  in  Fig.  1.  L-Thyroxine  was  added  at 
1 X  10  -5 ~, GSH at 0.01 M, and DNP at 5 X  10  -5 ~. 
periments, the action of these agents against GSH- 
induced  swelling  was  surveyed,  with  the  finding 
of  quite  characteristic  differences  between  GSH- 
and  thyroxine-induced  swelling. 
(a)  Action  of  2,4-dinitrophenol.  This  agent 
inhibits spontaneous  swelling of mitochondria and 
completely blocks the swelling action of thyroxine 
(1,  2).  Data  summarized  in Fig. 3  show  that  5  X 
10-  s  M  DNP  has  no  inhibitory  effect  on  mito- 
chondrial  swelling  induced  by  0.01  M  GSH,  al- 
though  this  concentration  of  DNP  completely 
blocks  the  action  of  1  X  10- ~ M thyroxine.  It  is 
evident  that  the  mechanism  of action  of  GSH  in 
inducing swelling must differ from that of thyrox- 
ine;  the  lack  of  response  to  DNP  also  suggests 
that  GSH acts  on some receptor site in  the mito- 
chondrion  which  may  be  less  directly  associated 
with  the  coupling  of  phosphorylation  to  respira- 
tion.  In  similar  experiments  it  was  found  that  5 
X  10  -5 ~  dicumarol failed to inhibit GSH-induced 
swelling, but  inhibited  thyroxine-induced  swelling 
completely. 
(b)  Action  of Mg  -H- and Mn  ++. Both  Mg  ++ and 
Mn  ++  inhibit  the  swelling  induced  by  thyroxine 
(1).  However  the  typical  experiments  shown  in 
Fig. 4 demonstrate that 0.005 M Mg  ++ has virtually 
no  ability  to  inhibit  swelling  induced  by  0.01  M 
GSH;  this  concentration  of  Mg  ++  suffices  for 
virtually complete inhibition of thyroxine-induced 
swelling  (1).  On  the  other  hand,  0.005  M  Mn  ++ 
completely  blocks  swelling  induced  by  GSH. 
Although Mn  ++ is known to catalyze autoxidation 
of cysteine,  oxidative removal of  the  GSH in  the 
test  system  during  the  test  period  was  relatively 
slow and  insufficient to account for the inhibitory 
action of Mn  ++ on the GSH swelling. 
FIG. 4.  Effect of Mg  ++ and Mn  ++ on GSH-induced 
swelling.  Conditions  arranged  as  in  Fig.  1;  the  con- 
centration of the MgCI2 and MnCI2 added was 0.005 ~r. 
FIG.  5.  Action  of  adenine  nucleotides.  Conditions 
as in Fig.  1. The nucleotides were added  to yield final 
concentration  of  0.003  M. 
The striking difference between Mn  ++ and Mg  ++ 
suggests  that  the  GSH-induced  swelling  may 
provide an approach  for identification of the locus 
of  the  specific action  of  Mn  ++  claimed  by  Lind- 
berg  and  Ernster  (13)  in  reactivating  oxidative 
phosphorylation  in aged and  swollen mitochondria 
and  for  the  extensive  accumulation  and  binding 
of Mn  ++  (7). 
(c)  Action  of adenine  nucleotides.  The  data  col- 
lected  in  Fig.  5  show  that  ATP  can  very largely 
prevent  the  swelling  action  of  GSH,  but  that 
equivalent  concentrations  of ADP  and  AMP  are 
inactive,  as  is  inorganic pyrophosphate.  By  con- 
trast,  in fresh mitochondria tested under  the same 
conditions  both  ADP  and  pyrophosphate  as  well 
as ATP protect against thyroxine-induced swelling 
(1, 4). In similar tests it was found that GTP and 
ITP were as effective as ATP in protecting against 
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protection  whatsoever.  However, when  the  stock 
mitochondrial  suspension  in  0.25  M  sucrose  was 
aged  at  0  °  for longer  than  2  hours,  then  none  of 
the  nucleoside  5'-triphosphates  protected  against 
GSH-induced swelling. 
There is now evidence that ATP can exert both 
specific and  non-specific action  against  mitochon- 
drial  swelling  (15,  16,  3).  ATP,  but  not  ADP, 
can  reverse  swelling,  presumably  because  of  a 
specific  capacity  to  act  as  a  phosphate  donor. 
However, it may also act as a  chelating agent for 
divalent  metal  ions  such  as  Ca  ++  (14);  ADP, 
inorganic  pyrophosphate,  and  other  nucleoside 
5r-triphosphates  have  similar  action  and  can 
also  inhibit  swelling.  Presumably  ATP  has  some 
specific  action  in  the  inhibition  of  GSH-induced 
swelling,  since  ADP  and  pyrophosphate  are  not 
effective. On  the  other  hand,  inhibition  of  GSH- 
induced  swelling  by  concentrations  of  ethylene- 
diaminetetraacetate  (EDTA) as low as 1 X  10  -4 
was  observed.  EDTA  also  inhibits  thyroxine-in- 
duced  swelling (1),  but appears  to be less potent. 
(d)  Effect  of  sucrose. In  a  medium  containing 
0.75  M sucrose,  the swelling action  of thyroxine  is 
completely abolished  (3),  but  similar  experiments 
showed  that  this  concentration  of  sucrose  does 
not  significantly  inhibit  the  swelling  induced  by 
GSH. The inhibitory effect of high concentrations 
of  sucrose  on  thyroxine-induced  and  spontaneous 
swelling appears  to  be  caused  by  inhibition of an 
intermediate  enzymic reaction  in  the  coupling  of 
phosphorylation  to  electron  transport,  a  process 
which  controls  the  contractility  of  the  mitochon- 
drial membrane  (3).  The lack of effect of sucrose 
FIG.  6.  Effect of serum  albumin.  Conditions  as  in 
Fig.  1, with  1.0  X  10  -5 M thyroxine or 0.005  M GSH 
added  as  shown.  Bovine serum  albumin  (crystallized, 
Armour)  was  added  as  shown  in  concentration  of  10 
mg. per ml. test medium. 
FIG. 7. Effect of pH. The rate of swelling in the pres- 
ence of 0.01  ~  GSH was tested in a  medium of 0.3  M 
sucrose  buffered with tris-histidine mixtures as shown. 
The optimum pH curve of thyroxine-induced swelling 
is shown in the dotted line.  The rates were arbitrarily 
measured  as the reciprocal of  the  half-times to  reach 
the  limiting  optical  absorbancy. 
on  GSH-induced  swelling  indicates  that  GSH 
acts  on  some  other  susceptible  site  in  the  mito- 
chondrial  structure  less  directly  associated  with 
coupled phosphorylation. 
(e)  E,%ct  of  high  particle  weight  solutes.  Both 
bovine  serum  albumin  (SA)  and  polyvinylpyr- 
rolidone (PVP)  (particle weight ca. 60,000)  inhibit 
spontaneous  and  thyroxine-induced  swelling,  and 
this  action  appears  to  depend  on  the  inability of 
these  agents  to  pass  through  the  mitochondrial 
membrane(s)  (3), so that these solutes can provide 
a  "colloid"  osmotic  pressure  difference  between 
extra-  and  intramitochondrial  phases.  Experi- 
ments  such  as  shown  in  Fig.  6  demonstrate  that 
bovine  serum  albumin  (between  1.0 and  100  rag. 
per  ml.  medium)  does  not  prevent  the  swelling 
induced by GSH, but does completely block swell- 
ing induced  by  thyroxine.  Similarly it was  found 
that  7.7  per  cent  PVP  is  also  ineffective in  pre- 
venting  swelling  induced  by  GSH.  From  these 
findings it may be  suggested  that  swelling induced 
by  GSH  causes  a  change  in  permeability  of  the 
mitochondrial membrane(s)  so that high molecular 
weight  solutes  such  as  PVP  and  serum  albumin 
penetrate  the  membrane,  permitting  no  substan- 
tially  large  osmotic  pressure  gradient  between 
intra-  and  extramitochondrial  phases  to  exist 
when  such  solutes  are  added.  This  interpretation 
is  also  supported  by  the  finding  described  below 
that  considerable  protein  is  lost  from  the  mito- 
chondria  during  GSH-induced  swelling. 
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the effect of pH on the rate of GSH-induced swell- 
ing are shown in Fig. 7. It is seen that the optimum 
is at pH 6.5 or lower, and that the rate is far from 
maximum at pH 7.5.  Most of the experiments on 
GSH-induced swelling in  this paper were carried 
out at pH 7.4 and are thus not maximum in rate. 
On  the  other  hand,  both  spontaneous  and  thy- 
roxine-induced swelling are maximum  at pH  7.5 
(3) and occur only very slowly, if at all, at pH 6.5. 
These  findings  furnish  additional  evidence  that 
GSH-induced swelling is different in nature from 
thyroxine-induced swelling. 
Action  of Respiratory  Inhibitors.--It  has  been 
demonstrated that thyroxine-induced swelling can 
be completely prevented by  the  three character- 
istic  respiratory  chain  inhibitors  cyanide,  anti- 
mycin A, and  sodium  amytal in  the presence of 
02 and the respiratory chain reductant fl-hydroxy- 
butyrate  (3,  17).  These  findings  suggested  that 
swelling induced by thyroxine does not occur when 
the  DPN  of  the  mitochondria is  entirely in  the 
reduced  state,  regardless of  the  oxidation-reduc- 
tion state of the rest of the carriers. 
The  effect  of  varying  the  oxidation-reduction 
state of segments of the respiratory chain on  the 
swelling action of GSH was studied, with  the re- 
sults shown in Fig. 8. It is seen that maintenance 
of all the carriers in the reduced state with cyanide 
caused complete inhibition of the swelling action 
of  GSH.  However,  it is  seen  that  GSH  swelling 
was not prevented by amytal (DPN  reduced, all 
other carriers oxidized) or by antimycin A  (DPN, 
GSH 
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Fla. 8. Effect of respiratory inhibitors. Test systems 
arranged exactly as in preceding  communication  (3); 
cyanide was  0.001 ~;  antimycin A,  0.12 micrograms 
per ml.; and sodium amyta], 0.0018 ~. Inhibitor tubes 
contained  also  O.OOt ~  DL-/3-hydroxybutyrate  as  re- 
spiratory chain reductant. 
flavoprotein,  and  cytochrome  b  reduced;  cyto- 
chromes  c,  a,  and  a~ oxidized). It is  quite  clear 
that  GSH-  and  thyroxine-induced swelling differ 
very strikingly in  their  dependence on  the  state 
of  the respiratory carriers. Whereas  the  swelling 
action of  thyroxine appears  to  be  dependent  on 
the oxidation-reduction state of DPN,  the action 
of GSH appears not  to correlate with  the oxida- 
tion-reduction  state  of  DPN,  flavoprotein,  and 
cytochrome b, but is apparently dependent on the 
oxidation state of the segment of the respiratory 
chain between cytochromes c and aa, giving swell- 
ing when these are oxidized, but no swelling when 
these are in the reduced state. Alternative explana- 
tions (cf. reference 17) will be considered below. 
Antagonism  between Thyroxine  and GStt  in the 
Swelling Reaction.--In  Fig. 9  is shown  the inter- 
action of thyroxine and  GSH.  When tested sepa- 
rately, they showed their characteristically differ- 
ent kinetics and extent of the swelling. When both 
agents  were  present  together,  swelling  still  en- 
sued. However it is quite clear that the GSH and 
thyroxine appear to have some antagonistic action, 
at least on  the  terminal phase  of swelling, since 
the  characteristic  approach  to  complete  loss  of 
optical absorbancy ordinarily produced  by  GSH 
does not occur when thyroxine is also present. The 
course of the swelling induced by the combination 
of GSH and thyroxine is thus not greatly different 
from that given by thyroxine alone. These findings 
suggest that there may be a  common intermediate 
stage in  the two modes of swelling in which thy- 
roxine may prevent the much more drastic swelling 
action of GSH. The significance of these findings is 
discussed below. 
Reversal  of GSH-Induced Swelling.--Thyroxine- 
induced  or spontaneous  swelling can be reversed 
"passively,"  by  addition  of  impermeant  solutes 
such as PVP or serum albumin to the test medium, 
the  mitochondria  then  presumably  behaving  as 
"passive" osmometers; or swelling can be reversed 
"actively,"  i.e.  through  enzymatic  action,  by 
adding ATP  in  saline media  (3).  Similar experi- 
ments revealed however that  GSH-induced swell- 
ing cannot be either prevented or "passively" re- 
versed by PVP  or serum  albumin, suggesting an 
irreversible action of GSH on the permeability of 
the mitochondrial membrane to these high molecu- 
lar weight solutes. 
Tests  were,  therefore,  made  for  the  ability of 
ATP, and combinations of ATP, Mn  4+,  and oxi- 
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FIG, 9. Antagonism of GSH and thyroxine in swelling of mitochondria. Conditions as in Fig. 1; L-thyroxine was 
1.0 X  I0  -~  x~  and  GSH,  0.005  g. 
TABLE I 
Loss of Nucleotides and Protein Following 
GSH-I~luced Swelling 
Basic test systems contained 5.0 ml. 0.30 M sucrose- 
0.02  ~  tris  buffer pH  7.4,  with 0.01  M GSH or  1  X 
10  -~  ~  L-thyroxine as  shown.  A  standard  aliquot  of 
mitochondria,  equivalent to  the  yield from 0.15  gin. 
fresh rat liver, was added to each tube. The tubes were 
incubated  30  minutes  at  20  °,  during which the  GSH 
and thyroxine had induced characteristic and maximal 
swelling.  The tubes were centrifuged and  the absorb- 
ancy of the clear supernatant fluids determined at 280 
m/z  and  260  m~.  Readings  of a  zero time  tube were 
subtracted in each case. 
Control ............. 
GSH-swollen  ......... 
Thyroxine-swollen .... 
Protein in 
medium 
rag.  per ml. 
0.013 
0. 265 
0.000 
Total 
nucleotides in 
medium 
micromoles  per ml. 
0.013 
0.083 
0.023 
ing,  in  both  sucrose  and  KC1  media.  However, 
although  these  agents  can  reverse  spontaneous 
and  thyroxine-induced  swelling  (3,  17)  and  can 
prevent  GSH-induced  swelling,  they  have  shown 
no  ability  whatsoever  to  reverse  GSH-induced 
swelling  once  it  has  reached  a  point  where  the 
suspension  has  achieved  almost  complete  optical 
transparency.  However  when  ATP  and  Mn  ++ 
were  added  at  points  during  the  characteristic 
precipitous  drop  in  optical  absorbancy  (in  a  KC1 
medium)  the  further  decrease  in  absorbancy 
could often be prevented but never reversed. It is 
possible  that  in  its  early stages  the  GSH-induced 
swelling may still be enzymically reversible. 
Loss  of  Intramitochondrial  Material  during 
GSH-Induced  Swelling.--The  data  in  Table  I 
show that considerable  material  absorbing  at 260 
m/z and  also at 280 m/z is lost from mitochondria 
to  the  suspending  medium  after  GSH-induced 
swelling  has  taken  place,  indicating  the  loss  of 
both protein  and  nucleotides.  On  the other hand, 
much smaller losses of 260 m/z and 280 m/z-absorb- 
ing  material  occurred  during  thyroxine-induced 
swelling.  These  findings  are  in  agreement  with 
the  relatively  drastic  and  irreversible  type  of 
swelling produced by GSH and  the milder and re- 
versible swelling induced by thyroxine. 
It  appears  very  unlikely,  however,  that  GSH 
produces  frank  lysis  or  rupture  of  the  mitochon- 
dria,  since  centrifugal  recovery  of  GSH-swollen 
mitochondria yields very voluminous pellets from 
the  nearly  clear  suspensions,  which  contain  con- 
siderably  more  water  than  pellets  of  thyroxine- 
swollen  mitochondria  recovered  under  the  same 
conditions. 
DISCUSSION 
The  results  of  this  investigation  indicate  that 
reduced glutathione and other naturally occurring 
thiols  such  as  cysteine  and  coenzyme  A  must  be 
added  to the relatively limited list of intracellular 
substances  capable  of  greatly  increasing  the  rate 
of  mitochondrial  swelling,  which  includes  inor- 
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pounds.  Of  these  thiols, reduced  glutathione  oc- 
curs  in  highest  concentrations  in  most  tissues, 
sufficiently  high  to  give  nearly  maximal  mito- 
chondrial swelling rates when  added in  vitro. 
Because these thiols promote a  type of swelling 
of mitochondria which  differs in kinetics, extent, 
and  other  characteristics from  thyroxine-induced 
swelling,  it  is  probable  that  the  thiols  act  on 
specific  chemical  receptors  in  the  mitochondria 
and  cause  changes  in  the  structure  and  physical 
properties of the mitochondria which  are charac- 
teristic and  different from  those induced by thy- 
roxine.  The  complex  structure  of  the  mitochon- 
drion, which has at least two kinds of membrane 
and  also inner  compartmentation, obviously per- 
mits  more  than  one  mode  of  structural  change 
which could lead to swelling. Possibly other physio- 
logically occurring  swelling  agents  may  yet  be 
found which will yield still other types of response. 
Although GSH reacts with or involves receptor 
sites in the mitochondria which are obviously dif- 
ferent  from  those  affected by thyroxine or phos- 
phate (presumably a bound form of mitochondrial 
DPN  (3,  5,  19)),  the GSH swelling also seems to 
involve  the  respiratory chain  and  the  coupling 
mechanism.  Thus,  ATP  and  Mn  ++  prevent  the 
GSH  swelling.  Furthermore,  inhibition  of  the 
respiratory  chain  with  cyanide,  but  not  with 
amytal or antimycin, leads to inhibition of GSH- 
induced  swelling.  In  addition,  the  presence  of 
thyroxine  prevents  or  antagonizes  the  normal 
action of  GSH in producing the final,  drastically 
swollen end-state. 
The  experiments  on  the  action  of  respiratory 
inhibitors on  GSH-induced  swelling are  of  some 
interest, since they have a pattern quite different 
from  that observed with  thyroxine-induced swell- 
ing. They suggest that the action of GSH is con- 
nected  with  the  function  of  that  portion  of  the 
respiratory chain between cytochrome c or cl and 
oxygen, in such a manner that the swelling action 
of  GSH  occurs  only  when  this  segment  of  the 
respiratory chain is in  the oxidized state. Reduc- 
tion of the rest of the chain does not seem to af- 
fect  the  GSH-induced  swelling.  Chappell  and 
Greville have suggested an alternative explanation 
for the inhibition of swelling by agents capable of 
blocking the  respiratory chain,  namely  that  res- 
piration  and  phosphorylation  are  necessary  for 
swelling to  occur  and  that  any  respiratory  in- 
hibitor  will  inhibit  swelling  (18).  Although  ex- 
periments  in  this  and  the  preceding  paper  (3) 
also agree that swelling is dependent on the exist- 
ence of some kind of "high-energy" intermediate 
generated  by respiration or ATP,  the  oxidation- 
reduction state of the carriers is believed to repre- 
sent an  additional factor of significance, in  view 
of the striking effects of the oxidation states of the 
carriers on ATPase and the ATP-Pi  a  exchange in 
mitochondrial fragments  (20,  21). 
Cysteine and  glutathione  are  oxidized via  the 
cytoehrome  system  in  mitochondria.  However, 
this  process  requires  addition  of  external  cyto- 
chrome  c,  and  no  phosphorylation  is  observed 
coupled  to  this  oxidation  (22).  Some  tests  with 
P~Mabelled phosphate indicated that no significant 
uptake of P~* into  the intramitochondrial nucleo- 
tides takes place during the course of GSH-induced 
swelling  in  the  presence  of  antimycin  A.  l~-As- 
corbate, also a reducing agent capable of reacting 
with the cytochrome system but with high yields 
of  coupled phosphorylation  (23),  does not  cause 
mitochondrial swelling. 
Recent studies by Lester et al.  (24) suggest that 
a  substituted  quinone,  namely  "Q~Td'  or  ubi- 
quinone  (25),  may be an essential electron carrier 
preceding cytochrome c.  Such  quinones  could be 
expected to interact with thiols to produce either 
respiratory chain inhibition or interference in the 
coupling  of  phosphorylation,  depending  on  the 
precise  nature  of  their  function  in  respiration. 
BAL,  cysteine,  and  other  thiols  do  in  fact  in- 
hibit  respiration  under  certain  conditions  (26). 
GSH and  cysteine, although  readily oxidized by 
mitochondria,  do  not  ordinarily  yield  coupled 
phosphorylation,  although  ascorbic  acid,  which 
similarly is  capable of  reducing  cytochrome c,  is 
oxidized with  a  high  efficiency of phosphate cou- 
pling (23), suggesting that the thiol group has an 
inhibitory action as well as the ability to reduce 
cytoehrome  c.  Furthermore,  cysteine and,  under 
some conditions, also glutathione uncouple phos- 
phorylation  associated  with  oxidation  of  fl-hy- 
droxybutyrate  and  other  substrates  by  mito- 
chondria (22, 23, 27). These considerations suggest 
a possible point of attack of thiols on the respira- 
tory  chain  and  also on  the  relationship between 
the action of the chain and the membrane proper- 
ties. Interference with  the function  of mitochon- 
drial lipoie acid or coenzyme A  also appear to be 
possible mechanisms for this action of GSH. 
The  antagonistic  action  of  thyroxine  on  the 
GSH-induced swelling is of some interest in con- 
nection  with  the  finding  of  Staehelin  (28)  that 116  MITOCHONDRIAL SWELLING 
thyroxine prevents  the  inhibitory action  of  cys- 
teine on respiration of mitochondria, and also with 
the finding of Park et al. (29)  that GSH is capable 
of preventing  the  uncoupling  of phosphorylation 
brought about by thyroxine in hamster liver mito- 
chondria.  Possibly  GSH-induced  swelling  and 
thyroxine-induced  swelling  share  some  common 
chemical or morphological stage, permitting such 
an antagnomism to occur. 
It can be predicted from  the  inhibitory action 
of ATP  and Mn  -H- toward GSH-induced swelling 
in vitro  that  in  the intracellular environment  the 
drastic swelling action of  GSH would be largely 
opposed and prevented by these agents, as would 
also appear to be the case for the swelling action 
of  thyroxine,  which  is  successfully  opposed  by 
ATP, Mg  ++, and intracellular soluble protein (3). 
GSH could thus be visualized as participating in 
a  dynamic balance of factors regulating the size, 
shape,  and  function  of the  mitochondrion in  its 
cytoplasmic environment.  Since GSH can lead to 
irreversible swelling, it is conceivable that  under 
certain  circumstances  it  may  participate  in  the 
intracellular degradation or lysis of mitochondria 
which has  often  been postulated  to  be a  normal 
event in a  turnover cycle of biogenesis and decay 
of mitochondria. 
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